Detailansicht

Wissensnetz

Person

Sven Wach (1976-)

Physiker

Name	Sven Wach
Zeit	1976- (Lebensdaten)
Ort	Erlangen (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. rer. nat.
Beruf	Physiker (charakteristischer Beruf)
Weitere Angaben	Diss. Universität Erlangen-Nürnberg, Naturwissenschaftliche Fakultät II - Biologie, Chemie, Pharmazie (2008)
Datensatztyp	Person
GND-Nummer	136517390
Datensatz-ID	136517390
Beteiligt an alle anzeigen Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes Expression of human Piwi-likegenes is associated with prognosis for soft tissue sarcoma patients Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients Einfluss von Komplementrezeptor-2-Polymorphismen bei der Pathogenese des systemischen Lupus erythematosus Einfluss von Komplementrezeptor-2-Polymorphismen bei der Pathogenese des systemischen Lupus erythematosus

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Sven Wach (1976-)

Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma

MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma

RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes

Expression of human Piwi-likegenes is associated with prognosis for soft tissue sarcoma patients

Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients

Einfluss von Komplementrezeptor-2-Polymorphismen bei der Pathogenese des systemischen Lupus erythematosus

Einfluss von Komplementrezeptor-2-Polymorphismen bei der Pathogenese des systemischen Lupus erythematosus